ORTHOPAEDIC TRAUMA ASSOCIATION
(click skeleton for image map)
Session I - Polytrauma - Thursday, October 5, 2006
Session II - Femur - Thursday, October 5, 2006
Session III - Reconstruction - Thursday, October 5, 2006
Session IV - Foot & Ankle - Friday, October 6, 2006
Session V - Pediatrics - Friday, October 6, 2006
Session VI - Spine - Friday, October 6, 2006
Session VII - Pelvis - Friday, October 6, 2006
Session VIII - Basic Science - Friday, October 6, 2006
Session IX - Injury Prevention - Saturday, October 7, 2006
Session X - Geriatrics - Saturday, October 7, 2006
Session XI - Tibia - Saturday, October 7, 2006
Session XII - Upper Extremity - Saturday, October 7, 2006
The material presented at the 22nd Annual Meeting has been made available by the Orthopaedic Trauma Association for educational purposes only. The material is not intended to represent the only, nor necessarily best method or procedure appropriate for the medical situations discussed, but rather is intended to present an approach, view, statement or opinion of the faculty which my be helpful to others who face similar situations.
The OTA disclaims any and all liability for injury or other damages resulting to any individual attending the annual meeting and for all claims which may arise out of the use of the techniques demonstated therein by such individuals whether these claims shall be asserted by physician or any other person.
FDA Approval
A middot ("·") indicates the FDA has not cleared this drug and/or medical device for the use described in this presentation (i.e., the drug or medical device is being discussed for an "off label" use). A double middot ("· ·") indicates that FDA information was not available at time of printing.
Disclosure
The names of authors presenting the papers on the Scientific Program are printed in boldface. The paper presenter was responsible for querying the co-authors regarding the disclosure of their work. Paper authors whose presentations have a * by the title have indicated they or their co-authors (department) received something of value (in excess of $500) from a commercial company or institution which relates directly or indirectly to the subject of their presentation. The OTA does not intend this identification to decrease the value of the presentation or to imply bias. It is intended solely for information.
To follow ACCME guidelines the OTA/AAOS has identified the options to disclose as follows:
An indication of the participant's disclosure appears after his or her name as well as the commercial company or institution that provided the support.
A triangle indicates presentation was funded by a grant from the Orthopaedic Trauma Association.